Zimmer Holdings Given New $100.00 Price Target at Deutsche Bank (ZMH)
Investment analysts at Deutsche Bank lifted their price objective on shares of Zimmer Holdings (NYSE:ZMH) from $98.00 to $100.00 in a note issued to investors on Friday, Analyst Ratings Net reports. Deutsche Bank’s price objective would suggest a potential upside of 7.48% from the company’s current price.
Zimmer Holdings (NYSE:ZMH) traded up 0.16% during mid-day trading on Friday, hitting $93.19. 211,057 shares of the company’s stock traded hands. Zimmer Holdings has a 52-week low of $72.24 and a 52-week high of $97.86. The stock has a 50-day moving average of $93.9 and a 200-day moving average of $87.08. The company has a market cap of $15.934 billion and a price-to-earnings ratio of 23.58.
Zimmer Holdings (NYSE:ZMH) last posted its quarterly earnings results on Friday, January 31st. The company reported $1.36 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.62 by $0.26. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. Analysts expect that Zimmer Holdings will post $5.71 EPS for the current fiscal year.
A number of other firms have also recently commented on ZMH. Analysts at Cowen and Company raised their price target on shares of Zimmer Holdings from $84.00 to $96.00 in a research note to investors on Friday. Separately, analysts at Brean Capital raised their price target on shares of Zimmer Holdings from $90.00 to $111.00 in a research note to investors on Thursday. They now have a “buy” rating on the stock. Finally, analysts at Argus raised their price target on shares of Zimmer Holdings from $98.00 to $110.00 in a research note to investors on Thursday, January 16th. They now have a “buy” rating on the stock. Two research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $93.48.
Zimmer Holdings, Inc (NYSE:ZMH) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.